Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 17 | Shill Kimball CChief Financial Officer | Grant or award | A | — 325.0K sh | Apr 14, 2026 |
| 17 | White WilsonDirector | Grant or award | A | — 90.9K sh | Apr 14, 2026 traded Apr 10, 2026 |
| 17 | Lucas Steven JohnVP, Controller & CAO | Tax withholding | F | — 9,445 sh | Apr 14, 2026 traded Apr 11, 2026 |
| 17 | Crain Jeanne HDirector | Grant or award | A | — 1,500 sh | Apr 14, 2026 traded Apr 13, 2026 |
| 17 | Moorjani JaneshEVP, Chief Financial Officer | Grant or award | A | — 12.4K sh | Apr 14, 2026 traded Apr 10, 2026 |
| 17 | Ludford Mary EDirector | Grant or award | A | — 1,500 sh | Apr 14, 2026 traded Apr 13, 2026 |
| 17 | Allison EricChief Product Officer | Option exercise | M | — 53.5K sh | Apr 14, 2026 traded Apr 12, 2026 |
| 17 | Harmer RyanPrincipal Accounting Officer | Grant or award | A | — 60.0K sh | Apr 14, 2026 traded Apr 14, 2026 |
| 17 | Wan XinChief Technology Officer | Option exercise | M | — 5,500 sh | Apr 14, 2026 traded Apr 10, 2026 |
| 17 | Walcott Wanjiku JuanitaChief Legal & Bus Affairs Ofc. | Grant or award | A | — 291.8K sh | Apr 14, 2026 traded Apr 10, 2026 |
| 17 | Tuttle MattGeneral Counsel & Secretary | Grant or award | A | — 100.0K sh | Apr 14, 2026 traded Apr 14, 2026 |
| 17 | Hallinan Patrick DEVP, CFO & Chief Admin Officer | Option exercise | M | — 11.2K sh | Apr 14, 2026 traded Apr 12, 2026 |
| 17 | Donlan Daniel PCFO and Treasurer | Option exercise | M | — 11.7K sh | Apr 14, 2026 traded Apr 10, 2026 |
| 17 | Brau Donnelly JuliaChief Financial Officer | Grant or award | A | — 408.0K sh | Apr 14, 2026 traded Apr 10, 2026 |
| 17 | Anagnost AndrewDirector, President and CEO | Grant or award | A | — 52.8K sh | Apr 14, 2026 traded Apr 10, 2026 |
| 16 | Kohler DonaldCEO, PVH Americas | Tax withholding | F | $122K 1,350 sh | Apr 14, 2026 traded Apr 10, 2026 |
| 16 | Menu PhilippeChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $17K 3,725 sh | Apr 14, 2026 traded Apr 10, 2026 |
| 16 | Xu ZhenyuChief Scientific Officer | Open-market sale · 10b5-1 plan | SELL | $17K 3,706 sh | Apr 14, 2026 traded Apr 10, 2026 |
| 16 | Camblong JurgiDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $18K 3,732 sh | Apr 14, 2026 traded Apr 10, 2026 |
| 16 | Donlan Daniel PCFO and Treasurer | Tax withholding | F | $93K 4,597 sh | Apr 14, 2026 traded Apr 10, 2026 |
| 16 | Van Well DaanChief Legal Officer | Open-market sale · 10b5-1 plan | SELL | $11K 2,400 sh | Apr 14, 2026 traded Apr 10, 2026 |
| 16 | Goldman Lea RytzGlobal Brand President, TH | Tax withholding | F | $138K 1,522 sh | Apr 14, 2026 traded Apr 10, 2026 |
| 16 | Olsson FredrikCEO, PVH EMEA | Tax withholding | F | $122K 1,343 sh | Apr 14, 2026 traded Apr 10, 2026 |
| 16 | Raymond ChristieDirector | Grant or award | A | $76K 1,043 sh | Apr 14, 2026 traded Apr 10, 2026 |
| 16 | Camblong JurgiDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $40K 8,500 sh | Apr 14, 2026 traded Apr 10, 2026 |
| 16 | Muken RossPresident | Open-market sale · 10b5-1 plan | SELL | $17K 3,687 sh | Apr 14, 2026 traded Apr 10, 2026 |
| 16 | Testa Daniel M.Director | Option exercise | M | $198K 21.5K sh | Apr 14, 2026 traded Apr 10, 2026 |
| 16 | Savman DavidGlobal Brand President, CK | Tax withholding | F | $141K 1,550 sh | Apr 14, 2026 traded Apr 10, 2026 |
| 15 | Chakravarthy ArthiChief Legal Officer | Tax withholding | F | $25K 4,295 sh | Apr 14, 2026 traded Apr 8, 2026 |
| 15 | Pawlak Chad Lee Sr.Director, Chief Executive Officer, 10% Owner | Grant or award | A | — 250.0K sh | Apr 14, 2026 traded Apr 7, 2026 |
| 14 | Hao XinyanChief Operating Officer | Option exercise | M | — 7,500 sh | Apr 14, 2026 traded Apr 10, 2026 |
| 13 | Edgemond JamesCFO AND TREASURER | Option exercise · 10b5-1 plan | M | $1.35M 10.0K sh | Apr 14, 2026 traded Apr 13, 2026 |
| 13 | Singleton Mark LeonardSVP & CFO | Option exercise | M | — 13.0K sh | Apr 14, 2026 traded Apr 10, 2026 |
| 13 | D'Adamio AnthonySVP & General Counsel | Option exercise | M | — 9,925 sh | Apr 14, 2026 traded Apr 10, 2026 |
| 13 | Hallinan Patrick DEVP, CFO & Chief Admin Officer | Option exercise | M | — 3,852 sh | Apr 14, 2026 traded Apr 12, 2026 |
| 13 | Menu PhilippeChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $16K 3,400 sh | Apr 14, 2026 traded Apr 13, 2026 |
| 13 | Keene Ruth AnnEVP, Corp Affairs, CLO | Grant or award | A | — 7,785 sh | Apr 14, 2026 traded Apr 10, 2026 |
| 13 | Xu ZhenyuChief Scientific Officer | Open-market sale · 10b5-1 plan | SELL | $16K 3,400 sh | Apr 14, 2026 traded Apr 13, 2026 |
| 13 | Patak Stephen PaulChief Revenue Officer | Option exercise | M | — 2,500 sh | Apr 14, 2026 traded Apr 12, 2026 |
| 13 | Moll Laurent RChief Operating Officer | Open-market sale · 10b5-1 plan | SELL | $20K 1,003 sh | Apr 14, 2026 traded Apr 13, 2026 |